EEF2K and neoplasm: All the mice receiving an intravenous infusion of WT CEA CD8+ CAR-T cells survived at least 28 days after tumor induction, whereas the survival of the mice treated with eEF-2K KO CAR-T cells declined rapidly from day 15 onward (Fig. 5F).